A Tiny Upstart Takes Aim at Robotic Surgery
Intuitive Surgical's (NASDAQ: ISRG) robots enjoy a near monopoly in hospitals, but that could change following last week's FDA approval of TransEnterix's (NYSEMKT: TRX) Senhance. Senhance is a robotic system that assists surgeons performing laparoscopic surgeries. It offers advantages, including haptic feedback, that could differentiate it from Intuitive Surgical's da Vinci system. Will TransEnterix carve out a meaningful slice of this fast-growing market?
Intuitive Surgical's ground-breaking da Vinci systems are reshaping laparoscopic surgery.
Source: Fool.com
Intuitive Surgical Inc Stock
With 36 Buy predictions and not a single Sell prediction Intuitive Surgical Inc is an absolute favorite of our community.
With a current price of 445.35 € Intuitive Surgical Inc is right around the predicted target price of 449 €.